Literature DB >> 14608558

Dynamic coping behaviors and process of parental response to child's cancer.

Chao-Hsing Yeh1.   

Abstract

The purpose of this study was to identify a theoretical construct for the process that Taiwanese parents go through during their child's illness with cancer. Grounded theory methodology was used to gain insight into the parental responses to their child's devastating illness. One core category with five distinct components emerged from the data as parents developed their ability to endure the distress of caring for a child with cancer. "Coming to terms" was the core category. The five distinct components were as follows: confrontation of reality, management of treatments, cognitive/affective shifting, recognition of the situation, and adjusting appropriately. For the parents of those children whose illness proceeded with few complications and those children who had been successfully treated, these components had a sequential pattern. However, for parents of those children whose illnesses were more complicated, changes in clinical status occurred in rapid succession, or simultaneously. Emotional responses of these parents were dynamic; the stages were less obvious and not sequential.

Entities:  

Mesh:

Year:  2003        PMID: 14608558     DOI: 10.1016/s0897-1897(03)00054-5

Source DB:  PubMed          Journal:  Appl Nurs Res        ISSN: 0897-1897            Impact factor:   2.257


  2 in total

1.  Effects of illness representation, perceived quality of information provided by the health-care professional, and perceived social support on depressive symptoms of the caregivers of children with leukemia.

Authors:  Ozlem Bozo; Selin Anahar; Gizem Ateş; Evren Etel
Journal:  J Clin Psychol Med Settings       Date:  2010-03

2.  Objective and subjective factors as predictors of post-traumatic stress symptoms in parents of children with cancer--a longitudinal study.

Authors:  Annika Lindahl Norberg; Ulrika Pöder; Gustaf Ljungman; Louise von Essen
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.